Engineered Mesoporous Silica Nanoparticles Enhance Tumor Tissue Destruction and Modulate Tumor-Associated Macrophages at Reduced FUS Intensities
ACS Nano Medicine · 11.11.2026 · 1 (10) · 2658-2671
DOI: 10.1021/acsnanomed.6c00137 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano Medicine, online erschienen am 20.10.2026. Verfasst von Taylor R. Ausec und 6 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Gefördert von: U.S. Department of Education, National Science Foundation, National Institutes of Health.
Abstract (Originalsprache)
Histotripsy has become an increasingly popular option for treating certain types of cancers because it is noninvasive and focused. However, current modalities for histotripsy treatment use large focused ultrasound (FUS) intensities to damage tissue, which can cause off-target effects such as burns and injury to nearby tissue. To improve upon this technology, we have developed engineered mesoporous silica nanoparticles that seed cavitating bubbles at ultrasound intensities 2–3 orders of magnitude lower than those used clinically (≥1000 W/cm2, time-averaged). When combined with resiquimod, a potent Toll-like receptor 7/8 agonist, macrophages grown in a tumor spheroid model adopted more of an antitumor phenotype than spheroids treated with FUS alone. In a breast cancer mouse model, tumor-associated macrophages treated with resiquimod, engineered mesoporous silica nanoparticles, and FUS dosed at 15.1 W/cm2, but not at 2.58 W/cm2, became more activated, and we observed greater tissue destruction in tumors compared to saline controls. These results demonstrate a novel, modified ultrasound treatment strategy for solid tumors by employing engineered mesoporous silica nanoparticles as cavitation seeding agents.
Förderung
- U.S. Department of Education
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Ausec, T. R., Reichert, E. L., Saemundsson, S. A., Curry, S. D., Cha, J. N., Shields, C. W., & Goodwin, A. P. (2026). Engineered Mesoporous Silica Nanoparticles Enhance Tumor Tissue Destruction and Modulate Tumor-Associated Macrophages at Reduced FUS Intensities. ACS Nano Medicine, 1(10), 2658-2671. https://doi.org/10.1021/acsnanomed.6c00137
Vancouver
Ausec TR, Reichert EL, Saemundsson SA, Curry SD, Cha JN, Shields CW, et al. Engineered Mesoporous Silica Nanoparticles Enhance Tumor Tissue Destruction and Modulate Tumor-Associated Macrophages at Reduced FUS Intensities. ACS Nano Medicine. 2026;1(10):2658-2671. doi:10.1021/acsnanomed.6c00137
BibTeX
@article{Ausec2026,
author = {Ausec, Taylor R. and Reichert, Elizabeth L. and Saemundsson, Sven A. and Curry, Shane D. and Cha, Jennifer N. and Shields, C. Wyatt and Goodwin, Andrew P.},
title = {Engineered Mesoporous Silica Nanoparticles Enhance Tumor Tissue Destruction and Modulate Tumor-Associated Macrophages at Reduced FUS Intensities},
journal = {ACS Nano Medicine},
year = {2026},
volume = {1},
number = {10},
pages = {2658--2671},
doi = {10.1021/acsnanomed.6c00137}
}
EUVIMED